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Background: Determining the prevalence of doping in sport might be useful for anti-doping 
authorities to gauge the effectiveness of anti-doping policies implemented to prevent positive 
attitudes toward doping. Using questionnaires and personal interviews, previous investigations have 
found that the prevalence of doping might be different among different sports disciplines; however, 
there is no sport-specific information about the proportion of adverse and atypical findings in 
samples used for doping control. The aim of the present investigation was to assess the differences in 
the frequency of adverse analytical and atypical findings among sports using the data made available 
by the World Anti-Doping Agency.  
Method: The data included in this investigation were gathered from the Testing Figures Reports 
made available annually from 2003 to 2015 by WADA. These Testing Figures Reports include 
information about the number of samples analyzed, the number of adverse and atypical findings 
reported, and the most commonly found drugs in the urine and blood samples analyzed. A total of 
1,347,213 samples were analyzed from the individual sports selected for this investigation, and 
698,371 samples were analyzed for disciplines catalogued as team sports. 
Results: In individual sports, the highest proportions of adverse and atypical findings (AAF) were 
3.3% ± 1.0% in cycling, 3.0% ± 0.6% in weightlifting and 2.9% ± 0.6% in boxing. In team sports, the 
highest proportions of AAF were 2.2% ± 0.5% in ice hockey, 2.0% ± 0.5% in rugby and 2.0% ± 
0.5% in basketball. Gymnastics and skating had the lowest proportions 1.0%) for individual sports, 
while field hockey, volleyball and football had the lowest proportions for team sports (<1.5%).  
Conclusion: As suggested by the analysis, the incidence of AAF was not uniform across all sports 
disciplines, with the different proportions pointing to an uneven use of banned substances depending 
on the sport. This information might be useful for increasing the strength and efficacy of anti-doping 
policies in those sports with the highest prevalence in the use of banned substances.  
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1. Introduction 
Since the creation of the World Anti-Doping Agency (WADA) in 1999, there has been a 
strong anti-doping movement across sports organizations and governmental authorities, with the 
main objective being to reduce the prevalence and incidence of doping in sports.1 Although several 
important steps in this direction have been taken in the past 20 years, this objective is far from being 
fully achieved because at present the use of banned substances by elite athletes from different sports 
disciplines is a certainty.2 4 Some flaws in the current anti-doping system, including the low deterrent 
effect of the punishment established for athletes sanctioned for an anti-doping rule violation, the 
inclusion of substances on the banned list without proper scrutiny of their effects on physical 
performance, and the imperfections in the Therapeutic Use Exemption (TUE) protocol, may have 
contributed to the relatively low efficacy of anti-doping policies.5  
Determining the prevalence of doping in sport is important for all the entities involved in 
sports organization; however, assessment of the prevalence and the changes in the incidence of 
doping is particularly crucial for anti-doping authorities to gauge the effectiveness of their anti-
doping policies and the utility of the social and economic investment made to prevent positive 
attitudes toward doping. Even though it is impractical to identify the exact prevalence and incidence 
of doping in sport, various analyses have shown that intentional doping occurs in 14% 57% of the 
population of competitive athletes.6 9 Some of these investigations have used surveys based on the 
randomised response technique, which allows the athlete to maintain anonymity while answering 
questions about doping practices. However, the accuracy of these survey-based investigations is 
limited by the necessity for truthfulness,10 objectivity, and the necessity that  have an 
accurate knowledge of what is a doping misconduct.11 According to the results of doping control 
tests, it has been revealed that the percentage of samples containing banned substances has remained 
relatively stable at ~2.0% both before6 and after12 the creation of WADA, a lower proportion than the 
one found in investigations based on personal input.11 The assessment of the prevalence and 
incidence of doping in sport using the results of doping tests is an objective and robust method, but it 
suffers from the limitations of the small detection window that exists for specific prohibited 
substances13, the analytical capability of WADA-accredited laboratories at the time of analysis, and 
an inability to discern the legal use of prohibited substances for therapeutic purposes from the 
intentional use of banned substances to obtain a competitive advantage. 
To date, most of the strategies implemented to fight against doping have failed to consider the 
particularities of each sport discipline in terms of doping misconduct (prevalence and seasonal 
variations in the use of banned substances, the substances consumed and methods most used to 
consume them, and so forth). Determining the prevalence of doping practices and recognizing the 
differing attitudes that exist toward doping in various sports can aid in the management and 
implementation of plans for doping control tests in each sports discipline. It is likely that the use of 
anti-doping policies specifically designed to address the characteristics of doping misconduct in each 
sport can improve the effectiveness of current anti-doping strategies. However, the information 
needed to understand the differences in the prevalence of and attitudes toward doping among various 
sports is scarce, making it difficult to draw conclusions about which anti-doping measures to use.  
A few investigations have assessed the prevalence of doping in one or various sports, but the 
methods used to assess the prevalence of doping are diverse and hinder an objective comparison 
among sports. Doping in athletics, as measured by surveys, might be up to 57%.7 In addition, track 
and field might be one of the major factors affecting prevalence of doping in this 
sport,14 suggesting the existence of contrasting attitudes toward doping between countries. Likewise, 
the incidence of doping may be high in cycling since the use of doping agents was admitted by a high 
proportion of cyclists that complated a questionnaire about the use of doping agents in the past 3 
months.15 However, not all the investigations confirm this high prevalence of doping in cycling.16 In 
contrast, all the players in the 32 football teams classified for the Brazil 2014 World Cup were tested 
for doping control out of competition and there was not any case of intentional doping in the more 
than 1,000 samples analyzed.17 It has also been found18 that offers to use banned substances are 
received most often by speed and power athletes, followed by endurance athletes, then by 
participants in sports that require motor skills, and then by participants in team sports. However, 
athletes rarely admit the use of banned substances despite the ease with which they can obtain doping 
agents.18 These findings coincide with findings from other investigations that have reported that 
participants in individual sports were more prone to be involved in doping than participants in team 
sports.19 Furthermore, athletes practising individual sports that require motor skills are less likely to 
be involved in doping practices than athletes practising more physically-oriented individual sports.4 
Finally, track and field athletes, cyclists and weightlifters had a higher knowledge of anti-doping rule 
violations than their counterparts in other Olympic sports.20 Taken together, previous research 
suggests that differences exist among various sports in the prevalence of doping and 
attitudes toward doping.  
Because data has been gathered for only a few sports, an objective comparison of the 
prevalence/incidence of doping in various sports disciplines has not been possible. Thus, the aim of 
the present investigation was to analyse the frequency of and atypical findings reported by WADA-
accredited laboratories from 2003 to 2015 to assess the differences in the incidence of doping in 
various sports.  
 
2. Methods 
The data included in this investigation were gathered from the Testing Figures Reports made 
available annually from 2003 to 2015 by WADA. These Testing Figures Reports can be accessed 
from the WADA website, and they include information about the number of samples analyzed, the 
number of adverse and atypical findings(AAF) reported, and the most commonly found drugs in the 
urine and blood samples analyzed.21 The percentage of AAF was calculated for each sport as 
described below.To determine the presence of a prohibited substance or its main metabolites or 
markers in athletes participating in both Olympic and non-Olympic sports from 2003 to 2015, 
WADA-accredited laboratories analyzed a total of 3,103,974 samples. The current investigation 
presents an ad hoc analysis of the samples for 17 individual sports (Aquatics, Athletics, Boxing, 
Canoe/Kayaking, Cycling, Fencing, Gymnastics, Judo, Rowing, Shooting, Skiing, Skating, 
Taekwondo, Tennis, Triathlon, Weightlifting and Wrestling) and 7 team sports (Basketball, Football, 
Handball, Field Hockey, Ice Hockey, Rugby and Volleyball). All these sports were part of the 
Olympic programme during the analyzed period. (Information on Rugby was available only from 
2012 to 2015). For this investigation, only complex team sports were labelled as team sport , while 
other individual disciplines that have collective events (known as simple and aggregated team sports, 
including athletics, swimming, cycling, rowing, etc)22 remained labelled as individual sports because 
most of the samples analyzed came from the individual disciplines. The grouping of individual and 
team sports in the current analysis only responds to the intention of creating a more comprehensible 
manuscript, as some individual and team sports share physical, physiological and sociodemographic 
characteristics. Because it was impractical to analyze all the sports (more than 100) included in the 
WADA reports, the above-mentioned individual and team sports were selected because they 
accounted for at least 1,000 samples per year in all the years examined. 
The Testing Figures Reports have evolved from 2003 to 2015 and have presented more 
information about doping every year. However, we have used the data from 2003 as the basis for the 
analysis. In the reports from 2003 to 2007, 2 types of non-negative results were merged: a) adverse 
analytical findings (
and/or a metabolite of the substance that was included in the list of prohibited substances) and b) 
atypical findings (when the parameters measured by the laboratory showed a discrepancy with the 
previous results for the same athlete).  Notably, the analyses did not include information about 
Therapeutic Use Exemption; thus, adverse and atypical findings did not necessarily end in anti-
doping rule violations. The information on the number of samples obtained in competition and out of 
competition and the number of AAF have been analyzed using the reports from 2012 to 2015 because 
this information was not included in the previous reports. Finally, the blood samples collected for the 
our analysis because this type of sample had not 
been obtained during the entire period from 2003 to 2015. 
2.1 Statistical analysis 
The data were electronically extracted from the Testing Figures Reports and entered into a 
database designed for the purposes of this research. The data were extracted by one author (MAN) 
using a spreadsheet (Excel 2016, Microsoft Office, WA, USA) and then they were checked for 
accuracy by another author (JDC). Subsequently, the mean ±SD for each Olympic sport (individual 
or team) was calculated for span of years investigated (2003 2015). The normality of each variable 
was initially analyzed with the Shapiro-Wilk test. A one-way analysis of variance (ANOVA) was 
used to detect differences in the number of samples analyzed and in the frequency of AAF among 
sports. Afer a F significant test (inter-groups and intra-groups degrees of freedom), the Bonferroni 
post hoc analysis was employed to identify differences among individual sports and among team 
sports in these variables. The differences in the distribution of samples and the percentage of AAF 
between in-competition and out-of-competition settings were tested with crosstab and Chi square 
tests, including adjusted standardised residuals. Briefly, a sport that had a distribution of samples or 
percentage of AAF was considered to be statistically different from expected when its distribution of 
samples/findings in-competition and out-of-competition was > or < than the critical value of Z (i.e., 
1.96). The data were analyzed with the statistical package SPSS version 20.0 (SPSS Inc., Chicago, 
IL, USA). The significance level for all tests was set at p < 0.05.   
 
3. Results 
A total of 1,347,213 samples were analyzed from the individual sports selected for this 
investigation from 2003 to 2015, with an overall frequency of AAF of 1.6% ± 0.9%. In the team 
sports examined, the number of samples analyzed during this period was 698,371, with the overall 
frequency of AAF (1.7% ± 0.6%) being similar to individual sports. Table 1 depicts the average 
number of samples analyzed per year in all individual sports (F(16, 204) = 218.1; p(ANOVA) < 
0.001). Athletics was the individual sport with the highest number of samples analyzed per year, with 
a significantly greater number of samples being available than the remaining individual sports (p < 
0.01 in all pairwise comparisons). Cycling ranked second among the second individual sport in the 
number of samples analyzed per year and had higher values for adverse and atypical findings than all 
the remaining individual sports (p < 0.01 in all pairwise comparisons). Aquatics and weightlifting 
also had a higher number of samples analyzed per year than the remaining individuals sports (p < 
0.01 in all pairwise comparisons). Table 1 contains the number of AAF per sport from 2003 to 2015. 
In absolute values, cycling, athletics and weightlifting were the sports with the highest number of 
non-negative results. Table 1 also contains the average ± SD in the proportion of adverse and atypical 
findings in individual sports, which eliminates the influence of the differences in the number of 
samples analyzed in each individual sport (F(16, 204) = 24.6; p(ANOVA) < 0.001). Cycling, 
weightlifting and boxing were the individual sports with the highest proportion of AAF, with the 
percentages being greater than the remaining individual sports (p < 0.01 in all pairwise comparisons). 
Aquatics, rowing, shooting, gymnastics, and skating had the lowest proportion of AAF in the years 
studied, and their values were also lower than the proportions of adverse and atypical findings found 
in triathlon and wrestling (p < 0.01 in all pairwise comparisons).  
Table 1 presents information on the average number of samples analyzed (F (6, 84) = 262.7; 
p(ANOVA) < 0.001) in team sports. Football was the team sport with the highest number of samples 
analyzed per year, with a significantly greater number of samples than the remaining team sports (p < 
0.01 in all pairwise comparisons). Basketball ranked second in team sports in the number of samples 
analyzed per year, with a significantly greater number of samples than volleyball, ice hockey, 
handball and field hockey (p < 0.01 in all pairwise comparisons). Football, basketball and rugby were 
the team sports with the highest number of AAF. However, ice hockey and rugby were the team 
sports with the highest proportion of AAF (F (6, 84) = 8.1; p (ANOVA) < 0.001), with higher 
proportions than field hockey, volleyball and football (p < 0.05 in all pairwise comparisons). 
Basketball also had a higher proportion of adverse and atypical findings than volleyball (p = 0.01) 
and football (p = 0.01).  
Fig. 1 presents information about the number of samples analyzed per year in each sport. 
Overall, all sports tended to have an increase in the number of samples analyzed per year from 2003 
to 2015. In addition, most of the sports had the largest number of samples analyzed per year in 2015. 
Fig. 2 shows the changes in the percentage of AAF per year within each sport. Despite the increase in 
number of samples analyzed each year, there was not a clear tendency for a higher prevalence of 
AAF with time. In fact, some sports, such as cycling, boxing and triathlon, showed a progressive 
reduction in the percentage of adverse and atypical findings from 2003 to 2015.  
In individual sports, the overall proportion of samples obtained in competition was 53.1% ± 
3.3%, while the remaining 46.9% ± 3.3% were obtained out of competition. Skiing, tennis, rowing 
and shooting had unexpected distributions for the samples obtained in competition and out of 
competition (Fig. 3A, p < 0.05). In individual sports, the proportion of AAF in samples obtained in 
competition vs. out of competition was 67.8% ± 8.7% and 32.2% ± 8.7%, respectively. In this case, 
the distributions for the AAF in completion and of competition were different from those expected in 
triathlon, canoeing, fencing, rowing and shooting (Fig. 3B, p < 0.05). In team sports, the overall 
proportion of samples obtained in competition vs. out of competition was 56.3% ± 2.2% and 43.7% ± 
2.2%, respectively. Rugby, field hockey and football had in competition vs. out of competition 
distributions different from expected (Fig. 4A, p < 0.05). The proportion of AAF in samples obtained 
in competition vs. out of competition in team sports was 71.7% ± 10.9% and 28.3% ± 10.9%, 
respectively. Only rugby presented a distribution of adverse and atypical findings in samples in 
competition vs. out of competition different from what was expected (Fig. 4B, p < 0.05). 
4. Discussion 
The goal of this investigation was to evaluate the number of samples analyzed and the 
proportion of AAF found in some of the most popular sports through the use of data on samples 
analyzed by WADA-accredited laboratories between 2003 and 2015. To standardise the data during 
this period, we used the information provided in the Testing Figures Report of 2003, which grouped 
all the non-negative results (i.e., AAF) in the same category. The findings in this investigation were 
as follows: a) Cycling, weightlifting and boxing, which had a proportion of ~3.1% ± 0.7% for AAF 
during the examined period, ranked highest among the individual sports for AAF; b) ice hockey, 
rugby and basketball, which had a proportion of ~2.1% ± 0.5% for AAF during the examined period, 
ranked highest among the team sports for AAF; c) for most sports, the number of anti-doping 
controls increased yearly during the examined period, but this did not translate into a concomitant 
increase in the proportion of banned substances found in anti-doping controls; and d) for individual 
and team sports combined, the distribution of samples obtained in competition and out of competition 
was 55% and 45%, respectively, while the distribution of AAF in competition and out of competition 
was 70% and 30%, respectively. These results indicate that the incidence of AAF was not uniform in 
all sports disciplines, suggesting that some specific sports might present a greater use of banned 
substances. The increase in the number of anti-doping controls per year in most individual and team 
sports did not produce a higher percentage of AAF. In the future, focusing on samples obtained in 
competition might be more effective for identifying banned substances because most of the AAF 
were in the samples obtained in competition. This strategy might increase the strength and efficacy of 
anti-doping policies in those sports with the highest prevalence in the use of banned substances.  
The results of the current investigation suggest that the number of samples analyzed per year 
is not the primary reason that there was a greater proportion of AAF in a specific sport. Recent 
research that included all the doping control test results for 13 years produced similar findings.12 
Thus, both analyses provide evidence that anti-doping pressure should be focused on alternative 
strategies rather than on increasing the number of anti-doping controls. Table 1 indicates that the 
number of samples does not explain why some sports have higher percentages of AAF; thus, other 
causes might be responsible for the differences in the frequency of banned substances found among 
sports. In the current investigation, we analyzed the proportion of samples and AAF obtained in 
competition and out of competition within each sport, and we normalised the data to allow for a 
better comparison among sports. Interestingly, the individual and team sports with the highest 
incidence of adverse and atypical findings had a distribution of in-competition vs. out-of-competition 
samples comparable to the other sports analyzed. In this respect, the2 sports with the highest 
proportion of in-competition samples (rowing and football) did not present particularly high 
percentages of AAF (Figs. 3 and 4). On the other hand, while the overall distribution of samples was 
comparable between in-competition and out-of-competition samples, the percentage of AAF was 
higher in the samples obtained in competition. All this information taken together points to the fact 
that the number of samples or their distribution in competition and out of competition does not 
explain the differences in the percentages of AAF among sports.  
The explanation for the differences in the percentages of banned substances among sport 
disciplines found in this investigation probably includes other parameters not related to anti-doping 
pressure. For example, athletic success, financial gain, the assumption that other athletes also use 
banned substances23 and the 24 none of which are equal in all sports, might be behind 
the diverse sport-specific attitudes and beliefs toward doping misconduct. Although the reasons for 
the differences in the proportion of AAF among sports are not evident from the current analysis, it 
seems clear that doping is an uneven phenomenon of variable magnitude depending on the nature of 
the sports discipline. Interestingly, although the magnitude of the prevalence of doping is much 
higher when measured with anonymous surveys against doping control tests, the sports with the 
highest prevalence and incidence of doping are the ones that have used these 2 types of analyses.7, 15, 
17 19 The current analysis underlines the complex and idiosyncratic nature of the use of banned 
substances in sports,25 but it also suggests that some sports disciplines might be at a higher risk of 
doping misconduct. The study of the reasons for the differences in the proportion of AAF among 
sports warrants further investigation.  
Among individual sports, there is no a clear explanation for the higher proportion of banned 
substances in cycling, weightlifting and boxing when compared to the remaining disciplines. From a 
physiological standpoint, the physical capabilities linked to success in these 3 disciplines are quite 
different, with uneven involvements of muscle strength, muscle power and endurance among them. 
Thus, one might expect that, despite the similarities in the proportions of AAF in these individual 
sports, the most prevalent types of banned substances found in cycling, weightlifting and boxing 
would be different. Although cycling was the sport with the highest incidence of AAF for the period 
studied, the percentage of banned substances found in the ly declined over 
time (Fig. 2). It might be worth studying the strategies used to fight against doping in cycling, 
particularly the ones set in motion by the Union Cycliste Internationale (UCI) and by WADA, along 
with the recommendations made by the Movement For Credible Cycling. These strategies might be 
useful in other sports with high percentages of AAF.  
Regarding team sports, all of them share a common nature in that they require high-intensity 
actions intermittently combined with short periods of recovery; thus, success is driven by a reliance 
on anaerobic and aerobic metabolic pathways. However, the team sports with the highest proportion 
of AAF (ice hockey, rugby, and basketball) have similar physical demands when compared with the 
other team sports studies. Football was the team sport with the highest number of samples analyzed 
per year and with the highest proportion of samples obtained in competition. However, the 
percentage of AAF was low, suggesting that the use of banned substances in football is low. Finally, 
the frequency of AAF was similar in individual and team sports, probably because the factors that 
predispose athletes to doping are equally present in both individual and team disciplines.  
Previous research has established3, 6 that the most accurate way to estimate the prevalence and 
incidence of doping in elite sports is to use a combination of different anonymous questionnaires, 
specifically the survey technique called the randomised response technique. Other researchers4, 26 
have recommended using a combination of qualitative and quantitative measurements interviews, 
questionnaires and, ideally, less-invasive biomedical tests (e.g. based on hair or salivary samples)
to assess prevalence and incidence of doping in sports. Although these 2 multidisciplinary 
perspectives4, 6 are useful for the assessment of attitudes toward doping in research with only a 
limited number of participants, their application to large populations might be very complex or even 
unfeasible. Additionally, an ability to correctly identify doping misconducts can affect the 
outcomes of these types of investigations, and those who lie about their doping behaviours still are 
highly influential.11 The current analysis does not contain individual information directly obtained 
from athletes beyond the evidence provided by the analysis of the samples, and thus it precludes, in 
part, a knowledge and understanding of the motives and attitudes behind doping misconduct. 
However, our study did provide a robust scrutiny of all the samples analyzed for anti-doping 
purposes from 2003 to 2015, which strengthens the generalisability and utility of the results here 
presented. Given our results, it is safe to conclude that some individual sports, such as cycling, 
weightlifting, and boxing, and team sports, such as rugby, ice hockey and basketball, presented a 
statistically significant , and 
thus it is reasonable to assume that these sports are ones that present a greater use of prohibited 
substances.  
As was mentioned in the Methods section, the adverse and atypical findings presented in this 
investigation did not necessarily end in anti-doping rule violations. Some of the substances detected 
might have been used for therapeutic purposes under the TUE protocol, or the AAF might not have 
resulted in a formal sanction. Since 2013, WADA has published an annual report that relates the 
number of adverse and atypical findings to the proportion of anti-doping rule violations. In these 
reports, the overall proportion of AAF that ended in an anti-doping rule violation was 64% ± 1%, 
with approximately 10% ± 2% exemptions due to TUEs.  Interestingly, the remaining 26% ± 2% of 
AAF did not end in a sanction or they were still pending of a final decision which might affect the 
final number of AAF that ends in a sanction. The translation from adverse and atypical finding to 
anti-doping rule violations might also depend on the sport discipline. For example, from 2013 to 
2015, 85.5% ± 4.6% and 84.8% ± 1.5% of the AAF found in wrestling and weightlifting, 
respectively, finally ended in antidoping rule violations, while this proportion was only 23.3% ± 
14.3% in gymnastics. In team sports, the sport with the highest conversion of AAF into anti-doping 
rule violations was rugby (69.8% ± 5.5%) followed by volleyball (69.3% ± 23.7%). Thus, the data 
presented in this investigation are useful in assessing the use of banned substances in different sports, 
but the relationship between the number of AAF and the number of anti-doping rule violations 
among various sports requires further analysis.  
The current analysis has some limitations that should be considered when drawing 
conclusions about the use of banned substances in these sports. First, the Testing Figures Reports 
made public by WADA do not include information about the  even though this 
characteristic might affect the occurrence of misconduct regarding doping.14 The reports provided by 
WADA include information about the number of samples analyzed and the percentage of AAF in 
each WADA-accredited laboratory. However, this information cannot be extrapolated to infer the 
nationalities of the athletes whose samples were analyzed in each laboratory or the relationship 
prevalence of AAF. By including the ies 
in its reports, WADA could help us understand the nature of doping in various countries, especially 
after the recent independent investigations into doping practices that implicated Russian athletes, 
coaches, doctors, and the accredited laboratory based in Moscow.27 Second, reports do not 
include any analyses or information that allows us to differentiate between the occurrence of AAF 
and the sex of athletes. The sex of athletes might affect the prevalence and incidence of AAF, 
specifically as they relate to the concentration of hormones such as testosterone and to conditions in 
which androgens are elevated, such as disorders of sex development (DSD).28 The use of sex-specific 
information might help to identify discrepancies in the occurrence of doping misconduct among male 
and female athletes, but at present . Finally, 
n samples analyzed and substances found, but the use of 
banned substances in sports may be greater than recognized because not all athletes are under anti-
doping scrutiny and the methodologies used in the analyses are imperfect. Despite these limitations, 
the current analysis presents a broad vision of the frequency of AAF in sports.  
5. Conclusion 
In summary, the incidence of AAF reported by WADA-accredited laboratories was not 
uniform in all sports disciplines from 2003 to 2015. While some sports had a proportion of AAF 
above 3%, other disciplines did not even reach 1%. Thus, despite a concerted 
fight against doping, those who develop anti-doping strategies should consider the differences in the 
risk of doping among sports. Overall, the number of anti-doping controls has increased yearly in 
most sports, but this has not translated into a concomitant increase in the proportion of banned 
substances used in sports, except for cycling. Given the disproportionate distribution of AAF in 
competition and out of competition, more pressure should be exerted, in general terms, to obtain 
samples in competition, although this strategy should be designed specifically for each sport in the 
light of the current data. This information may be valuable to national and international anti-doping 
organisations in their efforts to improve the policies used to reduce doping practices in sports and to 
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Fig. 1 Number of samples analyzed per year between 2003 and 2015 in individual sports (A and B) 
and team sports (C).  
  
 
Fig. 2 Percentage of adverse and atypical findings (AAFs) per year between 2003 and 2015 in 





Fig. 3 (A) Proportion of samples obtained in competition and out of competition in individual sports 
and (B) distribution of the AAF in samples obtained in competition and out of competition. The data 
are mean ± SD for each sport between 2003 and 2015. * The distribution was different from that 
expected at p < 0.05. AAF = adverse and atypical finding; AQU = Aquatics; ATH = Athletics; BOX 
= Boxing; CAN = Canoe/kayaking; CYC = Cycling; FEN = Fencing; GYM = Gymnastics; JUD = 
Judo; ROW= Rowing; SHO = Shooting; SKA = Skating; SKI = Skiing; TAE = Taekwondo; TEN = 
Tennis; TRI = Triathlon; WEI = Weightlifting; WRE = Wrestling.  
 
Fig. 4 (A) Proportion of samples obtained in competition and out of competition in team sports and 
(B) distribution of the AAF in samples obtained in competition and out of competition. The data are 
mean ± SD for each sport between 2003 and 2015. * The distribution was different from that 
expected at p < 0.05. AAF = adverse and atypical finding; BAS = Basketball; FOO = Football; HAN 
= Handball; HOC = Field Hockey; ICE = Ice Hockey; RUG = Rugby; VOL = Volleyball.  
  
Table 1 Number of samples analyzed, number and percentage of AAF in individual and team sports 
between 2003 and 2015 (mean ± SD) 
Individual sport Samples (number) AAF (number) AAF (%) 
Individual sport 
Cycling 18371 ± 4018 572 ± 128 3.3 ± 1.0 
Weightlifting 7440 ± 1491$ 227 ± 75 3.0 ± 0.6 
Boxing 3303 ± 892* 92 ± 21 2.9 ± 0.6 
Triathlon 3069 ± 921* 61 ± 25 2.1 ± 0.8*  
Wrestling 4136 ± 1032* 78 ± 33 1.8 ± 0.5*  
Athletics 24132 ± 3516$ 379 ± 96 1.6 ± 0.3*  
Judo 3820 ± 752* 54 ± 27 1.4 ± 0.6*  
Skiing 4801 ± 989* 65 ± 23 1.4 ± 0.5*  
Taekwondo 1579 ± 332*  21 ± 7 1.3 ± 0.5*  
Tennis 3345 ± 686* 40 ± 13 1.3 ± 0.6*  
Canoe/kayaking 3559 ± 717* 45 ± 18 1.3 ± 0.5*  
Fencing 1836 ± 187* 22 ± 11 1.2 ± 0.5*  
Aquatics 12010 ± 1539$ 131± 44 1.1 ± 0.3*  
Rowing 4082 ± 865* 44 ± 19 1.1 ± 0.4*  
Shooting 2427 ± 469* 26 ± 26 1.1 ± 0.4*  
Gymnastics 2224 ± 316* 23 ± 10 1.0 ± 0.4*  
Skating 3496 ± 702* 32 ± 18 0.9 ± 0.5 
Team sport 
Ice Hockey 4004 ± 1187 89 ± 34 2.2 ± 0.5 
Rugby 5555 ± 1646 115 ± 53 2.0 ± 0.5 
Basketball 6951 ± 2457& 147 ± 87 2.0 ± 0.5 
Handball 3255 ± 720# 53 ± 16 1.6 ± 0.5 
Field Hockey 1723 ± 383 # 25 ± 14 1.4 ± 0.6&  
Volleyball 4194 ± 948# 55 ± 20 1.3 ± 0.4& # 
Football 28039 ± 4143$ 352 ± 121 1.2 ± 0.3& # 
* Different from cycling;  Different from weightlifting;  Different from boxing; # Different from 
basketball; & Different from ice hockey;  Different from rugby; $ Different from all the remaining 
sports within the same category. 
Abbrevation: AAF = adverse and atypical finding. 
